期刊
JOURNAL OF DERMATOLOGICAL SCIENCE
卷 99, 期 3, 页码 146-151出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.jdermsci.2020.06.001
关键词
RIPK1; Inflammation; Psoriasis; Systemic lupus erythematosus; Melanoma; Skin disease
类别
资金
- National Natural Science Foundation of China [81974479]
Skin diseases bring great psychological and physical impacts on patients, however, a considerable number of skin diseases still lack effective treatments, such as psoriasis, systemic lupus erythematosus, melanoma and so on. Receptor-interacting serine threonine kinase 1 (RIPK1) plays an important role in cell death, especially necroptosis, associated with inflammation and tumor. As many molecules modulate the ubiquitination of RIPK1, disruption of this checkpoint can lead to skin diseases, which can be ameliorated by RIPK1 inhibitors. This review will focus on the molecular mechanism of RIPK1 activation in inflammation as well as the current knowledges on the contribution of RIPK1 in skin diseases. (C) 2020 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据